Indian (NIFTY) Biotech Industry Analysis
UpdatedJun 03, 2023
DataAggregated Company Financials
Companies9
- 7D0.3%
- 3M5.7%
- 1Y-24.7%
- YTD-9.2%
The Biotech industry has stayed flat over the last week. Unfortunately though, the industry is down 25% over the past 12 months. Earnings are forecast to grow by 35% annually.
Industry Valuation and Performance
Has the Indian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 04 Jun 2023 | ₹313.3b | ₹120.8b | ₹4.5b | 40.1x | 69.9x | 2.6x |
| Tue, 02 May 2023 | ₹309.0b | ₹106.7b | ₹16.2b | 29.1x | 19x | 2.9x |
| Thu, 30 Mar 2023 | ₹268.2b | ₹106.6b | ₹16.4b | 22.4x | 16.4x | 2.5x |
| Sat, 25 Feb 2023 | ₹301.1b | ₹106.3b | ₹16.3b | 35.2x | 18.5x | 2.8x |
| Mon, 23 Jan 2023 | ₹326.2b | ₹99.2b | ₹18.0b | 31.1x | 18.2x | 3.3x |
| Wed, 21 Dec 2022 | ₹346.4b | ₹99.2b | ₹18.0b | 33.6x | 19.3x | 3.5x |
| Fri, 18 Nov 2022 | ₹375.2b | ₹100.5b | ₹17.3b | 35.1x | 21.7x | 3.7x |
| Sun, 16 Oct 2022 | ₹347.7b | ₹95.5b | ₹18.1b | 29.9x | 19.2x | 3.6x |
| Tue, 13 Sep 2022 | ₹399.7b | ₹95.5b | ₹18.1b | 34.3x | 22.1x | 4.2x |
| Thu, 11 Aug 2022 | ₹412.8b | ₹95.7b | ₹18.3b | 32.1x | 22.6x | 4.3x |
| Sat, 09 Jul 2022 | ₹422.9b | ₹92.1b | ₹17.7b | 32.1x | 24x | 4.6x |
| Mon, 06 Jun 2022 | ₹420.9b | ₹92.0b | ₹17.5b | 31.7x | 24x | 4.6x |
| Wed, 04 May 2022 | ₹479.6b | ₹85.4b | ₹6.9b | 61.1x | 69.2x | 5.6x |
| Fri, 01 Apr 2022 | ₹433.6b | ₹79.4b | ₹7.0b | 55.8x | 61.6x | 5.5x |
| Sun, 27 Feb 2022 | ₹500.9b | ₹79.4b | ₹7.0b | 54.5x | 71.1x | 6.3x |
| Tue, 25 Jan 2022 | ₹477.5b | ₹79.4b | ₹7.1b | 62.2x | 67.4x | 6x |
| Thu, 23 Dec 2021 | ₹467.7b | ₹76.2b | ₹6.9b | 65x | 67.8x | 6.1x |
| Sat, 20 Nov 2021 | ₹461.1b | ₹76.2b | ₹6.8b | 43.4x | 68.1x | 6.1x |
| Mon, 18 Oct 2021 | ₹441.0b | ₹75.2b | ₹7.1b | 60.3x | 62.4x | 5.9x |
| Wed, 15 Sep 2021 | ₹452.8b | ₹75.2b | ₹7.1b | 62.1x | 64x | 6x |
| Fri, 13 Aug 2021 | ₹468.2b | ₹75.2b | ₹7.1b | 64.5x | 66.2x | 6.2x |
| Tue, 08 Jun 2021 | ₹489.3b | ₹74.3b | ₹7.6b | 64.6x | 64.5x | 6.6x |
| Mon, 01 Mar 2021 | ₹483.4b | ₹72.0b | ₹6.1b | 76.2x | 79.1x | 6.7x |
| Thu, 03 Dec 2020 | ₹528.0b | ₹70.7b | ₹6.5b | 50.2x | 81.1x | 7.5x |
| Sun, 06 Sep 2020 | ₹473.2b | ₹74.2b | ₹5.1b | 45.5x | 92.9x | 6.4x |
| Wed, 10 Jun 2020 | ₹440.6b | ₹71.3b | ₹6.1b | 23.2x | 72.5x | 6.2x |
Price to Earnings Ratio
72.5x
Current Industry PE
- Investors are optimistic on the Indian Biotechnology industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 69.9x which is higher than its 3-year average PE of 55.3x.
- The 3-year average PS ratio of 5.5x is higher than the industry's current PS ratio of 2.6x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have declined 9.7% per year over the last three years.
- Meanwhile revenues for these companies have grown 19% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Indian Biotech compare with similar industries?
| IN Market | 0.86% | |
| Healthcare | 2.51% | |
| Biotech | 0.29% | |
| Biotech | 0.29% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BIOCON Biocon | ₹240.25 | 0.3% +₹954.5m | -25.0% | PE61.9x | |
| 532039 Zenotech Laboratories | ₹53.27 | 3.8% +₹119.6m | 3.8% | PE28.1x | |
| NIRMAN Nirman Agri Genetics | ₹99.00 | 20.2% +₹99.2m | n/a | PE23x | |
| 532041 Hindustan Bio Sciences | ₹8.78 | 65.0% +₹35.5m | 143.2% | PS16.9x | |
| 526139 Transgene Biotek | ₹4.06 | 2.3% +₹6.8m | 14.0% | PS219.6x |